Section 280e

By

02-06-2026

Pharma-Track Cannabis Company Challenges Rescheduling Order Over Regulatory Fairness

A pharmaceutical cannabinoid developer that built its entire business around federal compliance is now suing to undo the Trump administration's cannabis rescheduling order - arguing that the new

• MMJ International Holdings

By

15-05-2026

Rescheduling Order Lifts 280E Burden for Medical Cannabis Operators, Reshaping Banking Economics

The Acting Attorney General's order moving state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III of the Controlled Substances Act - effective April 22,

• Section 280E

By

11-05-2026

Federal Cannabis Rescheduling Moves Fast - Operators Need Answers Now

The federal government has taken its most concrete step toward rescheduling cannabis in decades, and the compliance clock for state-licensed medical operators is already ticking. A Department of

• Cannabis Rescheduling